Your Article Summary
See Latest ArticlesEfficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: Effects on nasal congestion
Allergy and Asthma Proceedings, 06/30/09
Prenner B et al. - Nasal decongestant activity of L/M was significantly higher than that of placebo and similar to that of PSE in symptomatic AR subjects. L/M showed a safety profile similar to placebo and was better tolerated than PSE. Thus, L/M offers a safe and efficacious alternative to PSE for the treatment of nasal congestion associated with AR.
Related Articles
Time Interval and the Factors Associated with the Development of Asthma in Patients with Allergic Rhinitis
Lung, 10/09/09
Relevance Score: 91%
Nonallergic Rhinitis Symptoms More Severe Than Allergic Rhinitis
ScienceDaily, 10/06/09
Relevance Score: 89%
Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis
Journal of Allergy and Clinical Immunology, 10/12/09
Relevance Score: 88%
Botox Sponge Replaces Needles for Rhinitis Patients
Ivanhoe, 10/19/09
Relevance Score: 87%
No Need For Needles: Botox Sponge Treats Intrinsic Rhinitis
ScienceDaily, 10/16/09
Relevance Score: 87%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers
Current Medical Research and Opinion, 12/08/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/07/09
Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers
Clinical Therapeutics, 12/07/09